Speakers
 |
EUROAPI
Laure Hugonet - Head of Innovation
IPCEI Med4CURE: a demonstration of EUROAPI’s commitment to strengthening the resilience of the EU health industry
|
 |
Novartis
Lucie Lovelle - Fellow by Novartis
Insight into the chemical development of Remibrutinib
|
 |
Roche
Paolo Tosatti - Principal Scientist, Process and catalysis development
Alternative Access to a Key Building Block for the Synthesis of SHP2 Inhibitor GDC-1971 |
 |
Johnson & Johnson
Matthieu Jouffroy - Sr. Principal Scientist, Discovery Process Research
Innovation on the critical path: from SAR enabling chemistry to GMP deliveries |
 |
Johannes G. de Vries
Catalytic conversion of renewable resources into bulk and fine chemicals |
 |
Holodiag
Pierric Marchand
Crystallization process: a cornerstone in chemical development
|
|
|
Minakem
Baptiste Fours - Scientist
Crystallization Challenges in a CDMO: The Role of Polymorphism
|
 |
Syngenta
Julien Vantourout - Group Leader Synthesis Chemistry
Investigating New Reactions in Crop Protection Research
|
 |
Lonza
Simon Wagschal - Head of External Innovation
Electrons over metals: powering greener pharma synthesis
|
 |
Axens group
Diego Alexander Peña Zapata - R&D engineer in heterogeneous catalysis
Co-processing in existing facilities: challenges, solutions
|
 |
Nuvisan
Jean-Guy Boiteau - Head of Chemical Development
The hunt for impurities
|
|
|
Sanofi
Anthony Bigot - Process Chemistry Route scouting expert
Adressing Sanofi’s Eco-design ambition through continuous synthesis and biocatalysis
|
|
Loading... 
